Carol Gleason

1.5k total citations
43 papers, 920 citations indexed

About

Carol Gleason is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carol Gleason has authored 43 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Immunology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carol Gleason's work include Biosimilars and Bioanalytical Methods (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Carol Gleason is often cited by papers focused on Biosimilars and Bioanalytical Methods (15 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Carol Gleason collaborates with scholars based in United States, Germany and United Kingdom. Carol Gleason's co-authors include Rashmi H. Barbhaiya, Kelly Pittman, Wen Chyi Shyu, R. Russell Martin, S. Thomas Forgue, Umesh Shukla, D.J. Weidler, C A Knupp, Richard B. Wilber and G. H. Hottendorf and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Carol Gleason

42 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Gleason United States 16 372 242 171 167 155 43 920
J Kneer Switzerland 15 224 0.6× 164 0.7× 93 0.5× 68 0.4× 109 0.7× 25 640
Susan K. Paulson United States 17 464 1.2× 170 0.7× 75 0.4× 125 0.7× 95 0.6× 31 1.7k
Stephen A. Bai United States 19 145 0.4× 157 0.6× 81 0.5× 32 0.2× 126 0.8× 34 847
Estelle Marrer Switzerland 11 94 0.3× 236 1.0× 64 0.4× 69 0.4× 83 0.5× 13 885
Kashyap Patel Australia 19 300 0.8× 299 1.2× 202 1.2× 54 0.3× 174 1.1× 43 1.1k
Jennifer L. Hoover United States 14 247 0.7× 308 1.3× 289 1.7× 118 0.7× 118 0.8× 23 883
Benjamin Weber United States 14 103 0.3× 188 0.8× 34 0.2× 61 0.4× 220 1.4× 34 870
Michael Seiberling Switzerland 21 93 0.3× 309 1.3× 45 0.3× 133 0.8× 221 1.4× 45 1.6k
Maobai Liu China 17 97 0.3× 125 0.5× 120 0.7× 37 0.2× 225 1.5× 87 815
Sarah L. Greig New Zealand 16 111 0.3× 329 1.4× 43 0.3× 71 0.4× 230 1.5× 28 932

Countries citing papers authored by Carol Gleason

Since Specialization
Citations

This map shows the geographic impact of Carol Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Gleason more than expected).

Fields of papers citing papers by Carol Gleason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Gleason. The network helps show where Carol Gleason may publish in the future.

Co-authorship network of co-authors of Carol Gleason

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Gleason. A scholar is included among the top collaborators of Carol Gleason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Gleason. Carol Gleason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Yan‐Shan, Huijin Dong, Carol Gleason, et al.. (2023). Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum. The AAPS Journal. 25(3). 35–35. 9 indexed citations
2.
Masilamani, Madhan, Vibha Jawa, Yan‐Shan Dai, et al.. (2023). Bioanalytical Methods for Characterization of CAR‐T Cellular Kinetics: Comparison of PCR Assays and Matrices. Clinical Pharmacology & Therapeutics. 114(3). 664–672. 6 indexed citations
3.
4.
Wickremsinhe, Enaksha, Qin Ji, Carol Gleason, Melanie Anderson, & Brian Booth. (2020). Land O’Lakes Workshop on Microsampling: Enabling Broader Adoption. The AAPS Journal. 22(6). 135–135. 14 indexed citations
5.
Gleason, Carol, Qin Ji, & Enaksha Wickremsinhe. (2020). Evaluation of Correlation between Bioanalytical Methods. Bioanalysis. 12(6). 419–426. 7 indexed citations
6.
Xu, Weifeng, Jennifer Cummings, Stephen M. Carl, et al.. (2018). Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing. Journal of Immunological Methods. 462. 34–41. 14 indexed citations
7.
Postelnek, Jennifer, Robert Neely, Michael Robbins, et al.. (2016). Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab. The AAPS Journal. 18(4). 989–999. 5 indexed citations
8.
Liu, Rong, Shannon Chilewski, Uma Kavita, et al.. (2016). Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform. The AAPS Journal. 19(1). 82–91. 4 indexed citations
9.
Jani, Darshana, John Allinson, Flora Berisha, et al.. (2015). Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development. The AAPS Journal. 18(1). 1–14. 54 indexed citations
10.
Myler, Heather, Matthew Hruska, Subasree Srinivasan, et al.. (2015). Anti-Peg Antibody Bioanalysis: A Clinical Case Study with Peg-Ifn-λ-1A and Peg-Ifn-α2A in Naive Patients. Bioanalysis. 7(9). 1093–1106. 28 indexed citations
11.
12.
Barbosa, Maria D.F.S., Carol Gleason, Flora Berisha, et al.. (2012). Addressing drug effects on cut point determination for an anti-drug antibody assay. Journal of Immunological Methods. 384(1-2). 152–156. 4 indexed citations
13.
Xu, Xiaohui, Qin Ji, Mohammed Jemal, et al.. (2012). Fit-For-Purpose Bioanalytical Cross-Validation for LC–MS/MS Assays in Clinical Studies. Bioanalysis. 5(1). 83–90. 14 indexed citations
14.
Sleeper, Meg M., et al.. (2008). Echocardiographic reference ranges for sedated healthy cynomolgus monkeys (Macaca fascicularis).. PubMed. 47(1). 22–5. 14 indexed citations
15.
Holzgrefe, Henry H., Icilio Cavero, Carol Gleason, et al.. (2006). Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 55(2). 159–175. 40 indexed citations
16.
Lentz, Kimberley A., et al.. (2006). Development and Validation of a Preclinical Food Effect Model. Journal of Pharmaceutical Sciences. 96(2). 459–472. 63 indexed citations
17.
Grimshaw, Charles E., et al.. (1997). Development of an equilibrium immunoassay using electrochemiluminescent detection for a novel recombinant protein product and its application to pre-clinical product development. Journal of Pharmaceutical and Biomedical Analysis. 16(4). 605–612. 12 indexed citations
18.
Srinivas, Nuggehally R., Wen Chyi Shyu, Carol Gleason, et al.. (1997). Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Clinical Pharmacology & Therapeutics. 62(4). 408–416. 6 indexed citations
19.
Barbhaiya, Rashmi H., Carol Gleason, Wen Chyi Shyu, et al.. (1990). Phase I study of single-dose BMY-28100, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy. 34(2). 202–205. 21 indexed citations
20.
Forgue, S. Thomas, Wen Chyi Shyu, Carol Gleason, Kelly Pittman, & Rashmi H. Barbhaiya. (1987). Pharmacokinetics of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys. Antimicrobial Agents and Chemotherapy. 31(5). 799–804. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kneer Breakdown of academic impact, for papers by Susan K. Paulson Breakdown of academic impact, for papers by Stephen A. Bai Breakdown of academic impact, for papers by Estelle Marrer Breakdown of academic impact, for papers by Kashyap Patel Breakdown of academic impact, for papers by Jennifer L. Hoover Breakdown of academic impact, for papers by Benjamin Weber Breakdown of academic impact, for papers by Michael Seiberling Breakdown of academic impact, for papers by Maobai Liu Breakdown of academic impact, for papers by Sarah L. Greig
Rankless by CCL
2026